Clinical significance of mucin phenotype, β-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma

British Journal of Surgery

Volumn 92, Issue 4, 2005, Pages 454-462

  Aihara, R ^a,c   Mochiki, E ^a   Nakabayashi, T ^a   Akazawa, K ^b   Asao, T ^a   Kuwano, H ^a  

^a Graduate School of Medicine   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MATRILYSIN; MUCIN; MUCIN 2; MUCIN 6;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CELL DIFFERENTIATION; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; PATIENT SELECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; UNDIFFERENTIATED CARCINOMA;

BETA CATENIN; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; PHENOTYPE; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 17144430935     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4868     Document Type: Article

References (30)

1. Nishi M, Omori Y, Miwa K. Japanese Classification of Gastric Carcinoma (1st English edn). Tokyo: Kanehara: 1995; 6-15.
2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49.
3. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 1968; 59: 251-258.
4. Makuuchi H, Kise Y, Shimada H, Chino O, Tanaka H. Endoscopic mucosal resection for early gastric cancer. Semin Surg Oncol 1999; 17: 108-116.
5. Shiraishi N, Adachi Y, Kitano S, Bandoh T, Katsuta T, Morimoto A. Indication for and outcome of laparoscopy-assisted Billroth I gastrectomy. Br J Surg 1999; 86: 541-544.
6. Hyung WJ, Noh SH, Lee JH. Early gastric carcinoma with signet ring cell histology. Cancer 2002; 94: 78-83.
7. Crawford HC, Matrisian LM. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1995; 14: 234-245.
8. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-573.
9. McDonnell S, Navre M, Coffey RJ Jr, Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 1991; 4: 527-533.
10. Adachi Y, Itoh F, Yamamoto H, Matsuno K, Arimura Y, Kusano M et al. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol 1998; 13: 1031-1035.
11. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998; 79: 187-194.
12. Liu XP, Kawauchi S, Oga A, Tsushimi K, Tsushimi M, Furuya T et al. Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res 2002; 93: 291-295.
13. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999; 18: 2883-2891.
14. Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 2002; 122: 60-71.
15. Watanabe H, Jass JR, Sobin LH. Histological Typing of Oesophageal and Gastric Tumours. WHO International Histological Classification of Tumours (2nd edn). Springer: Berlin: 1990.
16. Silva E, Teixeira A, David L, Carneiro F, Reis CA, Sobrinho-Simoes J et al. Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 2002; 440: 311-317.
17. Kim YS, Gum JR Jr. Diversity of mucin genes, structure, function, and expression. Gastroenterology 1995; 109: 999-1023.
18. Bara J, Gautier R, Daher N, Zaghouani H, Decaens C. Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae. Cancer Res 1986; 46: 3983-3989.
19. Bara J, Gautier R, Mouradian P, Decaens C, Daher N. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. Int J Cancer 1991; 47: 304-310.
20. Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999; 59: 1003-1007.
21. Tajima Y, Shimoda T, Nakanishi Y. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001; 61: 212-220.
22. Ajioka Y, Watanabe H, Jass JR. MUC1 and MUC2 mucin in flat and polypoid colorectal adenomas. J Clin Patbol 1997; 50: 417-421.
23. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 1994; 107: 1352-1363.
24. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000; 190: 437-443.
25. 5 Otsuji E, Yamaguchi T, Sawai K. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol 1998; 67: 216-220.
26. Bamba M, Sugihara H, Kushima R, Okada K, Tsukashita S, Horinouchi M et al. Time-dependent expression of intestinal phenotype in signet ring cell carcinoma of the human stomach. Virchows Arch 2001; 438: 49-56.
27. Yamachika T, Inada K, Fujimitsu Y, Nakamura S, Yamamura Y, Kitou T et al. Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 1997; 431: 103-110.
28. Kirchner T, Muller S, Hattori T, Mukaisyo K, Papadopoulos T, Brabletz T et al. Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchorws Arch 2001; 439: 512-522.
29. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 1992; 355: 846-847.
30. Yokota J, Sugimura T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 1993; 7: 920-925.